Regenerative Medical Technology (RMTG) Change in Accured Expenses (2018 - 2026)

Regenerative Medical Technology's Change in Accured Expenses history runs 9 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 62.23% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $6.7 million (up 67.82% YoY), while the FY2025 annual figure was $6.1 million, up 49.79% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $1.5 million, up from $1.4 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $3.2 million in Q3 2025, with the low at $413290.0 in Q4 2022.
• The 5-year median for Change in Accured Expenses is $908279.0 (2025), against an average of $1.0 million.
• The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses soared 2386.38% in 2022, then tumbled 35.59% in 2025.
• Regenerative Medical Technology's Change in Accured Expenses stood at $413290.0 in 2022, then soared by 111.96% to $875995.0 in 2023, then climbed by 19.13% to $1.0 million in 2024, then surged by 32.96% to $1.4 million in 2025, then grew by 6.2% to $1.5 million in 2026.
• Business Quant data shows RMTG's Change in Accured Expenses at $1.5 million in Q1 2026, $1.4 million in Q4 2025, and $3.2 million in Q3 2025.